-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Candel Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2022 to 2024.
- Candel Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $646 K, a 6.08% increase year-over-year.
- Candel Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $2.63 M.
- Candel Therapeutics, Inc. annual Interest Expense for 2023 was $2.6 M, a 51.9% increase from 2022.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)